Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

224 results
  1. ... versus placebo in adults with a sub-optimal response to CNS stimulants Figure 307 ADHD total symptoms (ADHD-RS, ... versus placebo in adults with a sub-optimal response to CNS stimulants View in own window Quality assessment No ...
  2. ... responses, and 10 of 20 patients achieved partial responses. CNS neurodegenerative syndrome There is no established optimal therapy for CNS neurodegenerative LCH, and assessment of response can be difficult.[ 42 ] It is not clear ...
  3. ... improvement in emotion regulation and orthostatic blood pressure response. CNS Neurosci Ther. 2009 Fall;15(3):255–63. ...
  4. ... strongest chemotherapy-associated risk occurred among survivors of CNS cancer. A significant dose response for CCNU was observed ( P < .01). In a ... years of treatment.[ 34 , 35 ] Evidence (radiation-dose response ... in children with CNS tumors indicates that growth hormone insufficiency can usually ...
  5. ... for interventions/outcomes of interest 174 Garcia 2019 CN-01958827 (Cochrane) Alcohol treatment response amonghispanic adolescents: a randomized trial No extractable or ...
  6. ... DG, Ilyas A, Mehta GU, et al.: Variable response of CNS hemangioblastomas to Pazopanib in a single patient with ...
  7. ... decarboxylase inhibitor) is the main therapy to correct CNS dopamine deficiency. Optimal therapeutic level is determined by clinical response. Note: (1) Dose-related dyskinesias may occur [ Abeling ...
  8. ... 12586451. Exclusion Code: X13. [ PubMed : 12586451 ] 146. Haile CN, Murrough JW, Iosifescu DV, et al. Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. Int J ...
  9. ... of 82%, while those with combined marrow and CNS disease at diagnosis had an EFS of only 61%. This study identified the response to prophase reduction as the most significant prognostic ...
  10. ... of dendritic cells of PLOSL patients link demyelinating CNS disorders with abnormalities in pathways of actin bundling and immune response. J Mol Med (Berl). 2007 Sep;85(9): ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last